Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Roles of cMET/ErbB3 activation and overexpression in the development or resistance to EGFR inhibitors in NSCLC patients.
- Authors
- Ahn, MJ[Ahn, Myung-Ju]; Park, S[Park, Silvia]; Sun, JM[Sun, Jong-Mu]; Ahn, JS[Ahn, Jin Seok]; Park, K[Park, Keunchil]; Langley, EJ[Langley, Emma J.]; Kim, PS[Kim, Phillip Sangwook]; Singh, S[Singh, Sharat]; Lockton, S[Lockton, Steve]
- Issue Date
- 20-May-2013
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.31, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 31
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.